rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
2006-3-30
|
pubmed:databankReference |
|
pubmed:abstractText |
Influenza A (H5N1) viruses could cause a severe worldwide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disruption. Effective vaccines against these viruses in humans are urgently needed.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1533-4406
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2006 Massachusetts Medical Society.
|
pubmed:issnType |
Electronic
|
pubmed:day |
30
|
pubmed:volume |
354
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1343-51
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16571878-Adolescent,
pubmed-meshheading:16571878-Adult,
pubmed-meshheading:16571878-Antibodies, Viral,
pubmed-meshheading:16571878-Dose-Response Relationship, Drug,
pubmed-meshheading:16571878-Double-Blind Method,
pubmed-meshheading:16571878-Female,
pubmed-meshheading:16571878-Hemagglutination Inhibition Tests,
pubmed-meshheading:16571878-Humans,
pubmed-meshheading:16571878-Immunization, Secondary,
pubmed-meshheading:16571878-Influenza, Human,
pubmed-meshheading:16571878-Influenza A Virus, H5N1 Subtype,
pubmed-meshheading:16571878-Influenza Vaccines,
pubmed-meshheading:16571878-Male,
pubmed-meshheading:16571878-Middle Aged,
pubmed-meshheading:16571878-Vaccines, Inactivated
|
pubmed:year |
2006
|
pubmed:articleTitle |
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
|
pubmed:affiliation |
Department of Medicine, University of Rochester, Rochester, NY, USA. john_treanor@urmc.rochester.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|